Media Summary: The Food and Drug Administration has approved the world's first medicine based on We've learned about a few techniques in biotechnology already, but the Dr. Dirk Hockemeyer (University of California, Berkeley) presented this lecture entitled “

Don Kohn Crispr Applications Gene Editing In Hematopoietic Stem Cells - Detailed Analysis & Overview

The Food and Drug Administration has approved the world's first medicine based on We've learned about a few techniques in biotechnology already, but the Dr. Dirk Hockemeyer (University of California, Berkeley) presented this lecture entitled “ Gladstone President Deepak Srivastava moderated a conversation with Jennifer Doudna and Shinya Yamanaka to discuss the ... Dr. Shengdar Tsai, Assistant Member, Experimental Hematology, St. Jude Children's Research Hospital. Casgevy is the first FDA-approved medical treatment based on

Agnieszka Czechowicz, MD, PhD, Stanford University, Stanford, CA, outlines the obstacles to in vivo Dr. Dirk Hockemeyer (Assistant Professor of A team of physicians and laboratory scientists has taken a key step toward a cure for sickle

Photo Gallery

Don Kohn: CRISPR Applications - Gene Editing in Hematopoietic Stem Cells
New CRISPR-based sickle cell treatment, explained
CRISPR-Cas9 Genome Editing Technology
Keynote: Gene Therapy Using Hematopoietic Stem Cells
CRISPR: Gene editing and beyond
CRISPR Applications in Human Stem Cells — Dr. Dirk Hockemeyer (2016 IGI CRISPR Workshop)
CRISPR Explained
The Convergence of CRISPR and Human Stem Cells
Precise Gene Editing of Human Pluripotent Stem Cells
Re-writing the Code of Life: CRISPR Systems and Applications of Gene Editing
Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies - Don Kohn
CRISPR Genome Editing for Sickle Cell Disease Therapies – Dr. Shengdar Tsai
Sponsored
Sponsored
View Detailed Profile
Don Kohn: CRISPR Applications - Gene Editing in Hematopoietic Stem Cells

Don Kohn: CRISPR Applications - Gene Editing in Hematopoietic Stem Cells

Don Kohn

New CRISPR-based sickle cell treatment, explained

New CRISPR-based sickle cell treatment, explained

The Food and Drug Administration has approved the world's first medicine based on

Sponsored
CRISPR-Cas9 Genome Editing Technology

CRISPR-Cas9 Genome Editing Technology

We've learned about a few techniques in biotechnology already, but the

Keynote: Gene Therapy Using Hematopoietic Stem Cells

Keynote: Gene Therapy Using Hematopoietic Stem Cells

by

CRISPR: Gene editing and beyond

CRISPR: Gene editing and beyond

The

Sponsored
CRISPR Applications in Human Stem Cells — Dr. Dirk Hockemeyer (2016 IGI CRISPR Workshop)

CRISPR Applications in Human Stem Cells — Dr. Dirk Hockemeyer (2016 IGI CRISPR Workshop)

Dr. Dirk Hockemeyer (University of California, Berkeley) presented this lecture entitled “

CRISPR Explained

CRISPR Explained

This video is an explanation of

The Convergence of CRISPR and Human Stem Cells

The Convergence of CRISPR and Human Stem Cells

Gladstone President Deepak Srivastava moderated a conversation with Jennifer Doudna and Shinya Yamanaka to discuss the ...

Precise Gene Editing of Human Pluripotent Stem Cells

Precise Gene Editing of Human Pluripotent Stem Cells

https://www.thermofisher.com/us/en/home/life-science/disease-modeling.html?cid= ...

Re-writing the Code of Life: CRISPR Systems and Applications of Gene Editing

Re-writing the Code of Life: CRISPR Systems and Applications of Gene Editing

Gene editing

Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies - Don Kohn

Hematopoietic Stem Cell Gene Therapy for Primary Immune Deficiencies - Don Kohn

Donald

CRISPR Genome Editing for Sickle Cell Disease Therapies – Dr. Shengdar Tsai

CRISPR Genome Editing for Sickle Cell Disease Therapies – Dr. Shengdar Tsai

Dr. Shengdar Tsai, Assistant Member, Experimental Hematology, St. Jude Children's Research Hospital.

Genome Editing with CRISPR-Cas9

Genome Editing with CRISPR-Cas9

This animation depicts the

CRISPR gene-editing treatment for sickle cell disease explained

CRISPR gene-editing treatment for sickle cell disease explained

Casgevy is the first FDA-approved medical treatment based on

Treating blood cell diseases with stem cell gene therapy | Donald Kohn, M.D.

Treating blood cell diseases with stem cell gene therapy | Donald Kohn, M.D.

Dr.

The CRISPR paper that changed science as we know it! A deep dive into the now-classic Jinek et al.

The CRISPR paper that changed science as we know it! A deep dive into the now-classic Jinek et al.

The

Challenges of in vivo gene editing for diseases of the hematopoietic system

Challenges of in vivo gene editing for diseases of the hematopoietic system

Agnieszka Czechowicz, MD, PhD, Stanford University, Stanford, CA, outlines the obstacles to in vivo

Genome Editing in Human Stem Cells — Dr. Dirk Hockemeyer (2015 IGI CRISPR Workshop_

Genome Editing in Human Stem Cells — Dr. Dirk Hockemeyer (2015 IGI CRISPR Workshop_

Dr. Dirk Hockemeyer (Assistant Professor of

CRISPR and Genome Editing: Treating Human Disease and Ethical Considerations

CRISPR and Genome Editing: Treating Human Disease and Ethical Considerations

This webinar introduces

Gene Editing Tool "CRISPR Cas9" paves way for Sickle Cell Cure | QPT

Gene Editing Tool "CRISPR Cas9" paves way for Sickle Cell Cure | QPT

A team of physicians and laboratory scientists has taken a key step toward a cure for sickle